GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 678 filers reported holding GLAXOSMITHKLINE PLC in Q4 2013. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $252,000 | -0.8% | 5,850 | 0.0% | 0.14% | -5.5% |
| Q2 2016 | $254,000 | -94.1% | 5,850 | -94.5% | 0.15% | -93.9% |
| Q1 2016 | $4,292,000 | -3.2% | 105,835 | -3.7% | 2.41% | -3.9% |
| Q4 2015 | $4,436,000 | +5.7% | 109,945 | +0.8% | 2.51% | +1.9% |
| Q3 2015 | $4,195,000 | -9.2% | 109,100 | -1.7% | 2.46% | +2.8% |
| Q2 2015 | $4,622,000 | -11.7% | 110,970 | -2.2% | 2.40% | -10.0% |
| Q1 2015 | $5,234,000 | +6.5% | 113,420 | -1.4% | 2.66% | +13.8% |
| Q4 2014 | $4,916,000 | -11.3% | 115,020 | -4.6% | 2.34% | -9.4% |
| Q3 2014 | $5,540,000 | -9.4% | 120,520 | +5.4% | 2.58% | -4.8% |
| Q2 2014 | $6,117,000 | -3.1% | 114,380 | -3.2% | 2.71% | -1.9% |
| Q1 2014 | $6,314,000 | -2.3% | 118,175 | -2.4% | 2.77% | -0.9% |
| Q4 2013 | $6,464,000 | +6.6% | 121,075 | +0.2% | 2.79% | +0.0% |
| Q3 2013 | $6,064,000 | -1.0% | 120,875 | -1.3% | 2.79% | -4.5% |
| Q2 2013 | $6,123,000 | – | 122,525 | – | 2.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |